Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Please share Science & Enterprise

AI Analysis Finds Serious Covid-19 Genetic Driver

Network graphic

A deep and multi-variable analysis of patients with serious Covid-19 respiratory symptoms finds the condition associated with abnormal expression of one gene. . . . → Read More: AI Analysis Finds Serious Covid-19 Genetic Driver

Infographic – Q3 2021 Venture Funds Continue Banner Year

Q3 2021 venture funds

Venture investors worldwide continue to look past the pandemic as investments in start-up enterprises rose to new levels in the U.S., Asia, and elsewhere. . . . → Read More: Infographic – Q3 2021 Venture Funds Continue Banner Year

Population Study Finds Genetic Links for Vertigo

Population genetics

A large-scale population genetics study finds several genetic variants associated with vertigo, a condition marked by dizziness and loss of balance. . . . → Read More: Population Study Finds Genetic Links for Vertigo

AI-Designed Antibodies for Start-Up Sought in Open Call

Computational biology illustration

An international consortium is seeking teams of scientists using algorithms to design new therapeutic antibodies, to form and fund a start-up company. . . . → Read More: AI-Designed Antibodies for Start-Up Sought in Open Call

European Life Science Venture Fund Raises €472M

Euro investments

A venture capital company raised €472 million ($US 548 million) for investments in life science and medical device start-ups in Europe. . . . → Read More: European Life Science Venture Fund Raises €472M

Crispr Licensed for Eye Disease Gene Therapies

Retinal gene therapy

A developer of inherited eye disease therapies is acquiring rights to the gene editing technology Crispr for treatments that work inside the eyes. . . . → Read More: Crispr Licensed for Eye Disease Gene Therapies

Precision Neuroscience Company Starts-Up, Raises $500M

Brain activity graphic

A new company is underway developing more precise therapies for psychiatric and neurodegenerative diseases based on genetics and data science. . . . → Read More: Precision Neuroscience Company Starts-Up, Raises $500M

Synthetic Antibody Company Goes Public in $230M Merger

Four fist bump

A developer of synthetic antibodies for inflammatory and skin disorders is becoming a public company through a special purpose acquisition-merger. . . . → Read More: Synthetic Antibody Company Goes Public in $230M Merger

Foundation Plans $1B for Longevity Research

Older couple

A charitable foundation began work today supporting research on human longevity, with the goal of increasing lifespans to more than 120 years. . . . → Read More: Foundation Plans $1B for Longevity Research

Trial Underway Testing Cancer Drug as Covid-19 Therapy

SARS-CoV-2 and cell

A clinical trial enrolled and dosed its first participant testing an oral drug, initially designed to treat cancer, as a therapy for mild Covid-19 infections. . . . → Read More: Trial Underway Testing Cancer Drug as Covid-19 Therapy